MLchartDataset catalogue

NY-ESO-1b peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015568

A recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino acid sequence SLLMWITQC, derived from the cancer-testis tumor antigen (NY-ESO-1), which is expressed on tumor cells of many different types, including melanomas. Vaccination with this peptide vaccine may elicit strong humoral and cellular immune responses to NY-ESO-1-expressing cancers.

Table 1. Record
IdentifierMLC-T-ONC-015568
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015568",
  "term": "NY-ESO-1b peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant nonapeptide used as an antineoplastic vaccine. NY-ESO-1b peptide vaccine contains the amino acid sequence SLLMWITQC, derived from the cancer-testis tumor antigen (NY-ESO-1), which is expressed on tumor cells of many different types, including melanomas. Vaccination with this peptide vaccine may elicit strong humoral and cellular immune responses to NY-ESO-1-expressing cancers.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/ny-eso-1b-peptide-vaccine/"
}

Record 12,044 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.